Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma

BACKGROUND: Most patients with hormone receptor (HR)-positive, human epidermal growth factor receptor type 2 (HER2)-negative breast cancer can be cured by surgery and endocrine therapy, but a significant proportion suffer recurrences. Actinin-4 is associated with cancer invasion and metastasis, and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Cancer
Asıl Yazarlar: Sugano, Teppei, Yoshida, Masayuki, Masuda, Mari, Ono, Makiko, Tamura, Kenji, Kinoshita, Takayuki, Tsuda, Hitoshi, Honda, Kazufumi, Gemma, Akihiko, Yamada, Tesshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7283275/
https://ncbi.nlm.nih.gov/pubmed/32265507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0821-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller